INTRODUCTION
============

In eukaryotic cells, the plasma membrane (PM) is a complex structure containing a plethora of lipid species ([@B47]). The lipids appear to be organized spatially in two major ways: phase separations in the plane of the membrane, creating microdomains ([@B63]), and, anisotropy transversely across the membrane, such that each leaflet of the bilayer has a distinct lipid composition ([@B33]). The latter property (referred to as bilayer asymmetry) was first reported for the erythrocyte PM ([@B41]) but is a property of the PM in every cell type ([@B27]; [@B122]). The outer leaflet of the PM contains predominantly phosphatidylcholine and sphingolipids, whereas the inner leaflet is enriched in phosphatidylethanolamine (PtdEth), phosphatidylserine (PtdSer), and phosphatidylinositol (PtdIns) and its phosphorylated derivatives (especially phosphatidylinositol 4-phosphate \[PtdIns4P\] and phosphatidylinositol 4,5-*bis*phosphate \[PtdIns(4,5)P~2~\] ([@B27]; [@B120]; [@B33]). Moreover, this lipid constitution is important for many PM functions, including nutrient transport ([@B30]), endocytosis ([@B80]), cell signaling ([@B43]), and cytokinesis ([@B31]; [@B66]). Phosphoinositides, in particular, have been implicated in polarity establishment ([@B102]), cytoskeletal dynamics ([@B56]), membrane trafficking ([@B29]), and signal transduction ([@B116]). The head groups of inner-leaflet glycerophospholipids recruit proteins that contain lipid-binding domains of the appropriate specificity ([@B28]; [@B53]; [@B72]; [@B105]), as well as other classes of proteins containing polybasic elements ([@B50]; [@B132]), membrane-insertion motifs ([@B3]), or curvature-inducing scaffolds ([@B60]).

Because of the influence that PM lipids exert on other cellular processes, how the localization and dynamics of inner-leaflet lipids are controlled is a biological question of substantial interest. In budding yeast (*Saccharomyces cerevisiae*), genetic analysis has implicated PM lipid asymmetry in several aspects of vesicle-mediated protein trafficking ([@B37]; [@B52]; [@B81]; [@B45]). Moreover, PtdIns(4,5)P~2~ is enriched at highly localized sites, such as at the bud neck ([@B12]) and endocytic patches ([@B109]). Similarly, a concentration of PtdSer appears to be important for proper localization of the small GTPase Cdc42 and its role in the development of cell polarity ([@B34]). Conversely, locally amassed PtdEth seems to be required for activation of the GTPase-activating proteins (GAPs) that down-regulate Cdc42-GTP ([@B94]) and/or for the guanine nucleotide dissociation inhibitor (GDI)--mediated dissociation of Cdc42 from the PM ([@B26]).

Bilayer asymmetry, in general, and the amount of any given inner-leaflet lipid, in particular, are maintained by active inward translocation ("flipping") concomitant with similar translocation outward of exoleaflet lipids ("flopping"; [@B24]; [@B122]). These movements are necessary in the face of continual exocytic vesicle insertion and endocytic vesicle removal, which act to scramble leaflet lipid content. In eukaryotes, inward translocation of PtdEth and PtdSer is catalyzed by members of a subfamily (class 4) of the P-type ATPases dubbed flippases ([@B25]; [@B113]; [@B96]; [@B65]). The *S. cerevisiae* genome encodes five flippases: Dnf1, Dnf2, Dnf3, Drs2, and Neo1 ([@B19]). Paralogues Dnf1 (1571; value in parentheses indicates number of residues) and Dnf2 (1612) localize primarily in the PM, whereas Dnf3 (1656), Drs2 (1355), and Neo1 (1151) are confined mainly to intracellular membranes ([@B25]; [@B73]). Exit of Dnf1 and Dnf2 from the ER and their insertion and function in the PM require their association with a smaller escort protein, Lem3/Ros3 (414; [@B57]; [@B77]); related proteins Crf1 (393; [@B93]) and Cdc50 (391; [@B70]; [@B111]) serve the same function for Dnf3 and Drs2, respectively. Such a factor has not yet been identified for Neo1 ([@B8]). Mutations in certain of the 14 human homologues of the yeast flippases ([@B64]) are causes of several inherited diseases ([@B35]; [@B121]).

The role of flippases in polarized growth is particularly intriguing because the PM undergoes rapid and highly directional expansion. One known control on PM flippase function is exerted by stimulatory phosphorylation by the Ser/Thr protein kinase Fpk1. The *FPK1* gene was first identified by loss-of-function mutations synthetically lethal with a *cdc50∆* mutation (which inactivates flippase Drs2), suggesting that Fpk1 action is needed for optimal activity of the remaining flippases. Indeed, although yeast cells lacking Fpk1 (and its paralogue, Fpk2/Kin82) are viable and did not have any change in flippase abundance or localization, they had a decreased ability to internalize fluorescently labeled PtdEth and PtdSer ([@B74]). In vitro purified Fpk1 directly phosphorylates four of the five flippases (not Neo1), with a marked preference for Dnf1 and Dnf2 ([@B74]). Fpk1 is, in turn, phosphorylated and inactivated by Ypk1 ([@B87]), a protein kinase whose function is up-regulated in response to membrane stress ([@B88]).

One biological stimulus in yeast that elicits highly polarized growth in haploid cells is exposure to mating pheromone ([@B97]). It was reported that PtdEth becomes detectable in the outer leaflet ([@B55]) and PtdSer become concentrated in the inner leaflet ([@B34]) at the leading edge of the projection (shmoo tip) that forms in pheromone-treated cells. Similarly, we demonstrated that PtdIns(4,5)P~2~ becomes enriched at the same location and is required for efficient recruitment of the mitogen-activated protein kinase (MAPK) scaffold protein Ste5 and maximal MAPK signaling ([@B39]). Hence we sought to determine whether plasma membrane lipid asymmetry and the flippases necessary to maintain it have any role in these processes. We examined the localization of the flippases and the flippase-regulating protein kinase Fpk1 upon pheromone exposure, used genetic analysis to determine that these proteins are indeed necessary for optimal pheromone response, and interrogated both wild-type and mutant cells using genetic, biochemical, and cell biological methods to determine how flippase action contributes to signal propagation.

RESULTS
=======

Flippase localization during pheromone response
-----------------------------------------------

As an initial means to determine whether any flippase might contribute to PM lipid dynamics necessary for cell morphogenesis and/or signaling during pheromone response, we examined the subcellular location of these enzymes. Toward this end, we successfully fused a fluorescent marker, either green fluorescent protein (GFP; [@B118]) or mCherry ([@B99]), in-frame to the C-terminal end of the chromosomal open reading frame for each of the four members of the yeast flippase family believed to reside in, or be trafficked into and out of, the PM ([@B25]; [@B113]; [@B96]). Using appropriate complementation tests, we found that these constructs, each of which is expressed at its endogenous level from its native promoter, retained full biological function ([@B86]; Rockwell and Thorner, unpublished results). The fifth flippase, Neo1, resides exclusively in internal membranes ([@B127]), and we found that its distribution (Supplemental Figure S1A) and level (Supplemental Figure S1B) were unaffected by pheromone treatment.

In naive cells, Dnf1-GFP and Dnf2-GFP resided in small puncta congruent with the PM disbursed reasonably uniformly around the cell periphery, especially in the PM of the bud (and, occasionally, at the bud neck), whereas the bulk of the Dnf3-GFP and Drs2-mCherry appeared to reside in cortical vesicles, in agreement with prior work indicating that Dnf3 mainly localizes to post-Golgi secretory vesicles and Drs2 in the *trans*-Golgi cisternae ([@B52]; [@B76]; [@B46]; [Figure 1A](#F1){ref-type="fig"}, left). Strikingly, within 1 h after exposure to pheromone, Dnf1-GFP, Dnf2-GFP and Dnf3-GFP were highly concentrated in the PM at the shmoo tip, whereas Drs2-mCherry remained in the Golgi compartment ([Figure 1A](#F1){ref-type="fig"}, middle). By 90 min after exposure to pheromone, although Dnf3-GFP still showed a bias at the shmoo tip, it seemed to reside mainly in endocytic vesicles, whereas Dnf1-GFP and Dnf2-GFP persisted in the PM at the shmoo tip and Drs2-mCherry remained in the Golgi body ([Figure 1A](#F1){ref-type="fig"}, right). These conclusions derived from standard epifluorescence microscopy were confirmed using confocal fluorescence microscopy (Supplemental Figure S2). Furthermore, immunoblot analysis of these proteins (or corresponding integrated constructs C-terminally tagged with a c-myc epitope) indicated that there was no pronounced change in the level of these proteins during the time course of pheromone treatment (Supplemental Figure S3). Thus these findings suggest that the marked relocalization exhibited by Dnf1, Dnf2, and Dnf3 places them in a position that could allow them to participate directly in membrane remodeling at the shmoo tip, the site from which signaling emanates ([@B39]) and at which polarized growth occurs ([@B67]).

![Flippase and flippase kinase localization in pheromone-treated cells. (A) *MAT***a** cells expressing the indicated flippase from its native promoter at its normal chromosomal locus as the sole source of each protein, Dnf1-GFP (NRY921), Dnf2-GFP (NRY923), Dnf3-GFP (YEB1), and Drs2-mCherry (YEB2), were grown to mid--exponential phase, exposed to α-factor (10 μM final concentration) for the indicated time, and viewed by fluorescence microscopy. (B) Cells (BY4741) expressing Fpk1-GFP from the *TPI1* promoter on a *CEN* plasmid (pFR150) were grown to mid--exponential phase in SCGlc-Leu-Trp and treated as in A. Scale bars, 5 μm.](134fig1){#F1}

The function of the flippases appears to be stimulated by the action of the protein kinase Fpk1 (and its paralogue Fpk2; [@B74]; [@B87]). Hence we used the same approach to monitor localization of Fpk1 and found that it too becomes markedly concentrated at the shmoo tip in pheromone-treated cells ([Figure 1B](#F1){ref-type="fig"}).

Flippases are essential to induce a pheromone response
------------------------------------------------------

To test whether the observed relocalizations are functionally significant and not merely the consequence of the highly directional secretion and cell growth that occurs during projection formation, we tested whether null alleles in one or more of these genes had any effect on the ability of the cells to respond to pheromone. This analysis was possible because, aside from Neo1, which is an essential gene ([@B82]), cells carrying complete deletions of any of the other four flippases, and even of any three together, are viable, although a *dnf1∆ dnf2∆ dnf3∆ drs2∆* quadruple mutant is inviable ([@B52]), indicating a significant degree of overlap in the physiological roles of these proteins. As a first means to assess pheromone responsiveness, we examined the frequency of shmoo formation in cultures of various combinations of *dnf1∆*, *dnf2∆*, *dnf3∆*, and *drs2∆* null alleles. As anticipated, no single deletion mutant displayed any significant defect in its efficiency of shmoo formation upon α-factor treatment ([Figure 2A](#F2){ref-type="fig"}), in keeping with the apparent redundancies in localization and function of these flippases ([@B25]; [@B96]). Indeed, even double-mutant combinations exhibited little or no reduction in shmoo formation or only a very modest (twofold) decrease, in the case of *dnf3∆ drs2∆* cells ([Figure 2A](#F2){ref-type="fig"}). In contrast, and in agreement with a largely shared function, we found that two triple mutants, *dnf1∆ dnf3∆ drs2∆* and especially *dnf1∆ dnf2∆ dnf3∆*, had a marked reduction in their ability to form a shmoo ([Figure 2A](#F2){ref-type="fig"}).

![Deletion of multiple flippases with overlapping function impairs pheromone response. (A) Exponentially growing cultures of cells of the indicated genotype (see [Table 1](#T1){ref-type="table"}) were exposed to 10 μM α-factor for 1.5 h and examined by microscopy. Values are the mean ± SD of three independent experiments. (B) WT (YLG32), *dnf1∆ dnf3∆ drs2∆* (YELO4), and *dnf1∆ dnf2∆ dnf3Δ* (YELO3) cells expressing a copy of a *FUS1~prom~-lacZ::URA3* reporter (pSB286) integrated at the *FUS1* locus were grown to mid--exponential phase, collected, resuspended in either YPD or YPD plus 10 μM α-factor, and, after 60 min, assayed for galactosidase activity. Values are the mean ± SD from three independent experiments.](134fig2){#F2}

The defect in shmoo formation exhibited by the two triple mutants we examined could arise from a defect in cell morphogenesis or from an inability to mount a pheromone response of any sort. To distinguish between these possibilities, we also monitored pheromone response by an independent assay, namely the ability to induce expression of a pheromone-responsive reporter gene, *FUS1* ([@B117]). For this purpose, a single copy of a *FUS1* promoter-driven *lacZ* construct was integrated at the *FUS1* locus in the two triple mutants and in otherwise isogenic wild-type cells as a control. As observed for shmoo formation, even 60 min after pheromone treatment, the *dnf1∆ dnf3∆ drs2∆* cells and especially the *dnf1∆ dnf2∆ dnf3∆* showed a dramatic reduction in reporter gene expression ([Figure 2B](#F2){ref-type="fig"}). Thus the defect in shmoo formation was attributable to a lack of signaling, regardless of whether the flippases may also have some role in the PM remodeling that may accompany highly polarized growth.

If flippase activity is critical for induction of pheromone response and the flippases require phosphorylation and activation by Fpk1 and Fpk2 for their optimal activity ([@B74]), then even otherwise wild-type cells (i.e., with a full complement of flippases) may have a defect in pheromone response if they lack these flippase-activating protein kinases. Consistent with this view, loss of neither Fpk1 alone nor Fpk2 alone had any significant effect on the efficiency of shmoo formation by otherwise wild-type cells, whereas an *fpk1∆ fpk2∆* double mutant exhibited a pronounced decrease ([Figure 3A](#F3){ref-type="fig"}). In this same regard, we described before that Fpk1 and Fpk2 are subject to inhibitory phosphorylation by the protein kinase Ypk1 ([@B87]). Hence we used high-level overexpression of Ypk1 as an independent means to impede Fpk1 and Fpk2 activity in otherwise wild-type cells and found that this tactic also caused a statistically significant drop in the frequency of shmoo formation, whereas neither empty vector nor a catalytically crippled mutant Ypk1(K376A; [@B91]) had any obvious effect ([Figure 3B](#F3){ref-type="fig"}). Collectively these findings indicated that flippase action contributes in some way to the competence of the cells to respond to pheromone. Hence we sought to determine what aspect of signal initiation or propagation is impaired in flippase-deficient cells.

![Fpk1 and Fpk2 function are required for optimal pheromone response. (A) Cultures of WT (BY4741), *fpk1Δ* (YFR191), *fpk2Δ* (YFR222), and *fpk1Δ fpk2Δ* (YFR205) cells were grown to mid--exponential phase in YPD medium, treated with 10 μM α-factor for 1.5 h, and examined by microscopy. (B) WT cells (BY4741) carrying empty vector (YEp352GAL) or the same vector overexpressing Ypk1 (pAM76), or *ypk1∆* cells (JTY6142) carrying YEp352GAL or the same vector overexpressing a KD mutant, Ypk1(K376), were grown to mid--exponential phase in SC-Ura+Raf/Suc medium, collected, and resuspended in SC-Ura+Gal medium, grown for an additional 3 h, incubated in the absence and presence of 10 μM α-factor for 1.5 h, and examined by microscopy. Values are the mean ± SD from three independent experiments.](134fig3){#F3}

Ste5 level is dramatically reduced in *dnf1∆ dnf2∆ dnf3∆* cells
---------------------------------------------------------------

All the initial steps of the mating pheromone response pathway take place in, or on the cytosolic surface of, the PM ([@B69]). Activation of the pathway in *MAT***a** cells is triggered by binding of α-factor pheromone to its cognate G protein--coupled receptor, Ste2 ([@B15]). It was reported recently in *Drosophila* that there was a marked reduction in the amount of an olfactory receptor (Or67d) inserted into the PM in the cilia on specific olfactory neurons that sense a male-specific pheromone in a mutant lacking the apparent fly orthologue (dATP8B) of mammalian flippase ATP8B1 ([@B48]), whose apparent homologues in *S. cerevisiae* are Dnf1 and Dnf2 ([@B35]; [@B121]). To test whether the amount of Ste2 delivered to the PM was affected in either of the yeast flippase triple mutants, we examined Ste2 localization in cells expressing a C-terminally mCherry-tagged version of the Ste2(7K-to-R) allele, which we demonstrated previously is functional but has markedly retarded ubiquitin-dependent endocytosis ([@B7]), making it easier to score the steady-state level of receptor in the PM. We found that delivery of Ste2(7K-to-R)-mCherry to the PM was not defective in either *dnf1∆ dnf2∆ dnf3∆* ([Figure 4A](#F4){ref-type="fig"}) or *dnf1∆ dnf3∆ drs2∆* cells (unpublished data); in fact, the level of Ste2(7K-to-R)-mCherry appeared to be somewhat higher in the *dnf1∆ dnf2∆ dnf3∆* mutant than in the corresponding control, consistent with the retardation of endocytosis described previously for cells deficient in both Dnf1 and Dnf2, especially at lower temperatures ([@B81]). Hence lack of PM-localized Ste2 cannot account for the inability of the multiply flippase-deficient cells to respond to pheromone.

![Steady-level of Ste5 is markedly decreased in *dnf1∆ dnf2∆ dnf3Δ* cells. (A) WT (YELO17) and *dnf1∆ dnf2∆ dnf3Δ* (YELO18) cells expressing Ste2(7K-to-R)-mCherry from the *STE2* promoter at the *STE2* locus were grown to mid--exponential phase in YPD and examined by fluorescence microscopy. Scale bar, 10 μm. (B) WT (BY4741) and *dnf1∆ dnf2∆ dnf3Δ* cells (PFY3272C) carrying plasmid pRS316-*GAL-STE4/STE18* were grown to mid--exponential phase in SC-Ura+Raf/Suc medium, collected, resuspended in SC-Ura+Gal, and examined after 8 h by microscopy. Values are the mean ± SD from three independent trials. (C) Cultures of *ste5∆* (YELO23) and *ste5∆ dnf1∆ dnf2∆ dnf3∆* (YELO24) expressing either Ste5-myc from plasmid p*STE5~prom~-STE5-myc~13~* or Ste5(NLSm)-myc from plasmid p*STE5~prom~-ste5(NLSm)-myc~13~* were grown to mid--exponential phase in SCGlc-Ura medium, collected, and lysed, and equal amounts of protein of the resulting whole-cell extracts were resolved by SDS--PAGE and analyzed by blotting with anti-myc monoclonal antibody and anti-Pgk1 as a loading control. Left, the lanes shown were separated on the original gel and have been spliced together here for clarity.](134fig4){#F4}

Focusing here, first, on the underlying cause of the inability of the *dnf1∆ dnf2∆ dnf3∆* cells to respond to pheromone, we took advantage of the fact that ectopic overexpression of the pheromone receptor--associated Gβγ complex (Ste4--Ste18) is known to induce all pathway outputs even in the absence of pheromone ([@B22]; [@B126]). Hence, if the signaling defect lies at or downstream of Gβγ action, then the *dnf1∆ dnf2∆ dnf3∆* mutant should be unresponsive to Ste4--Ste18 overexpression. However, we found no statistically significant difference between the *dnf1∆ dnf2∆ dnf3∆* cells and otherwise isogenic controls cells in shmoo formation ([Figure 4B](#F4){ref-type="fig"}) or any other readout of pheromone response (unpublished data) when Gβγ was overexpressed. Therefore we concentrated our attention on the factors that act at the nexus between receptor activation and the function of Gβγ.

Paramount among these factors is the MAPK cascade scaffold protein Ste5, whose signaling function requires its efficient recruitment to and stable association with the PM via insertion of an N-terminal amphipathic helix ([@B128]), interaction of its RING domain with Gβγ ([@B54]), and binding of its PH domain to PtdIns(4,5)P~2~ ([@B40]). Moreover, ample evidence implicates Ste5 as the rate-limiting component for initiation and maintenance of pheromone-evoked MAPK signaling ([@B112]; [@B38]; [@B114]). Strikingly, immunoblot analysis ([Figure 4C](#F4){ref-type="fig"}, left) revealed that the steady-state level of Ste5 was markedly lower in the *dnf1∆ dnf2∆ dnf3∆* mutant than in otherwise isogenic control cells and presumably below the threshold adequate for most cells in the population to mount an effective pheromone response. The decrease in Ste5 could be due either to a lower level of expression or to a higher rate of degradation (or both). Analysis of the level of Ste5 mRNA by quantitative reverse transcriptase-PCR showed that the amount of Ste5 transcript in *dnf1∆ dnf2∆ dnf3Δ* cells was indistinguishable from that in WT cells (unpublished data), indicating that the reduction in Ste5 protein was likely due to an increase in its rate of turnover.

Ste5, which undergoes robust nucleocytoplasmic shuttling ([@B84]; [@B68]; [@B61]), is targeted for degradation exclusively in the nucleus by the nuclearly localized ubiquitin:protein ligase (E3) SCF^Cdc4^ ([@B38]). Once sufficient Cln2 has built up to initiate the cell cycle, the cell is no longer susceptible to pheromone because Cln2-bound Cdk1/Cdc28 phosphorylates any PM-associated Ste5, ejecting it from the PM ([@B108]), thus allowing it to translocate into the nucleus and be degraded ([@B38]). We reasoned that if the lower steady-state level of Ste5 displayed by *dnf1∆ dnf2∆ dnf3Δ* cells was due to an enhanced rate of its degradation in the nucleus, then point mutations that eliminate the major nuclear localization signal (NLS) in Ste5 ([@B108]) might suppress the effect on Ste5 level observed in the multiple flippase--deficient cells. Indeed, when its major NLS was mutationally crippled, the steady-state level of Ste5 in *dnf1∆ dnf2∆ dnf3Δ* cells was restored to that seen in control cells ([Figure 4C](#F4){ref-type="fig"}, right). Therefore our attention turned to finding some mechanistic explanation for how loss of Dnf1, Dnf2, and Dnf3 might influence the processes that dictate Ste5 stability.

Factors contributing to Ste5 instability in *dnf1∆ dnf2∆ dnf3∆* cells
---------------------------------------------------------------------

Because the action of G1 cyclin-bound Cdk1/Cdc28 displaces Ste5 from the PM, permitting its nuclear entry and degradation, we first asked whether there was any effect of the loss of Dnf1, Dnf2, and Dnf3 on the level of Cln2. Unexpectedly, we observed even in asynchronous cultures a modest but reproducible increase in the steady-state level of this G1 cyclin in *dnf1∆ dnf2∆ dnf3∆* cells compared with the WT control ([Figure 5A](#F5){ref-type="fig"}). As an independent means to determine whether this moderate increase was enough to contribute to the lower level of Ste5 seen in *dnf1∆ dnf2∆ dnf3∆* cells, we reduced the total G1 cyclin-producing capacity of the cell by deleting both the *CLN1* and *CLN3* genes. This tactic more than doubled the relative level of Ste5 in *dnf1∆ dnf2∆ dnf3∆* cells ([Figure 5B](#F5){ref-type="fig"}) and, consistent with the elevation in Ste5 content, partially restored (a threefold increase) the ability of the cell population to respond to pheromone ([Figure 5C](#F5){ref-type="fig"}).

![Reduction in G1 cyclin activity partially rescues Ste5 protein level and pheromone responsiveness in *dnf1∆ dnf2∆ dnf3Δ* cells. (A) WT (BY4741) and derived *dnf1∆ dnf2∆ dnf3Δ* cells (PFY3272C) were grown to mid--exponential phase in YPD, collected, and lysed, and equal amounts of protein from the whole-cell extracts were resolved by SDS--PAGE and analyzed by immunoblotting with appropriate antibodies. Representative blot from three independent trials. (B) As in A, for WT, *cln1∆ cln3∆* (YELO38), *dnf1∆ dnf2∆ dnf3∆* (PFY3272C), and *cln1∆ cln3∆ dnf1∆ dnf2∆ dnf3∆* (YELO39) cells. (C) WT (BY4741) and *cln1∆ cln3∆* (YELO38), *dnf1∆ dnf2∆ dnf3∆* (PFY3272C), and *cln1∆ cln3∆ dnf1∆ dnf2∆ dnf3∆* (YELO39) cells were incubated with 10 μM α-factor for 1.5 h and examined by microscopy. Values are mean ± SD from three independent experiments.](134fig5){#F5}

We noted that a majority of the *dnf1∆ dnf2∆ dnf3∆* cells exhibited buds whose axial ratio was somewhat more elongated than in the corresponding wild-type cells (Supplemental Figure S4; see also, e.g., [Figure 6A](#F6){ref-type="fig"}). This morphological response can arise when the amount or activity of the cyclin B (Clb)--bound form of Cdk1/Cdc28 is compromised ([@B51]). Moreover, because Clb2-Cdk1 is known to phosphorylate and inhibit the SBF transcription factor required for expression of the G1 cyclin genes ([@B2]), a lower level of Clb-bound Cdk1 might explain the higher level of Cln2 we observed in *dnf1∆ dnf2∆ dnf3∆* cells. Consistent with this view, we found a modest but reproducible reduction in the cellular content of Clb2 in the *dnf1∆ dnf2∆ dnf3∆* cells as compared with the cognate control cells (Supplemental Figure S5).

![Flippase function increases inner-leaflet PtdSer and lowers outer-leaflet PtdEth. (A) WT (BY471) and isogenic *dnf1∆ dnf2∆ dnf3∆* (PFY3272C) cells carrying a *URA3*-marked *CEN* plasmid expressing GFP-C2^Lact^ from the *TDH3* (GAPDH/GPD) promoter were grown to mid--exponential phase in SCGlc-Ura medium, treated with 10 μM α-factor, and examined by fluorescence microscopy at the indicated time. (B) Cells shown in A were lysed, and equivalent amounts of protein from the whole-cell extracts were resolved by SDS--PAGE and analyzed with anti-GFP antibodies to detect the GFP-C2^Lact^ fusion protein and anti-Pgk1 antibodies as the loading control. (C) Equivalent numbers of WT (BY4741), isogenic *dnf1∆ dnf2∆ dnf3Δ* (PFY3272C), *dnf1∆ dnf2∆* (YELO9), *dnf1∆ dnf3∆* (YELO10), and *dnf2∆ dnf3∆* (YEL013) cells were each plated as a lawn in top agar on YPD plates, and sterile filter paper disks onto which 10 μl of a stock solution (8 mM) of duramycin had been spotted were immediately placed onto the lawn. After incubation for 2 d at 30°C, the plates were photographed. Response of *dnf2∆ dnf3∆* cells (not shown) closely resembled that of *dnf1∆ dnf3∆* cells.](134fig6){#F6}

One of the components required for bud emergence and timely progression through the apical-to-isotropic switch in bud expansion is the small Rho-family GTPase Cdc42 ([@B14]). It has been shown that Dnf1- and Dnf2-catalyzed PtdEth flipping to the inner leaflet is required for activation of the GAPs Rga1 and Rga2 that down-regulate Cdc42-GTP ([@B94]; and/or for the Rdi1-mediated dissociation of Cdc42 from the PM; [@B26]). In cells lacking Lem3 (the required escort protein and cofactor for Dnf1 and Dnf2), polarized Cdc42 persists, leading to continued apical bud growth at low temperatures, resulting in an elongated bud ([@B94]). Presumably the flippase defect of *dnf1∆ dnf2∆ dnf3∆* cells is even greater than of *lem3∆* cells, given that these cells manifest somewhat enlarged and elongated buds even at 30°C ([Figure 6A](#F6){ref-type="fig"}, left). It has also been reported that another flippase substrate, PtdSer, accumulates at bud necks, in the bud cortex, and at the tips of mating projections and that a PtdSer synthase (*cho1∆/pss1∆*) mutant has impaired polarization of Cdc42, causing a delay in bud emergence and defective mating ([@B34]).

To examine inner-leaflet PtdSer, we expressed, as a fusion to GFP, the C2 domain of the mammalian protein lactadherin (also known as MFG-E8), which is specific for binding to the head group of PtdSer ([@B100]; [@B132]; [@B131]). As expected, when compared with otherwise isogenic control cells, there was a marked decrease (nearly 60%) in the intensity of PM labeling with this probe in *dnf1∆ dnf2∆ dnf3Δ* cells, both before and after pheromone treatment ([Figure 6A](#F6){ref-type="fig"}; average PM pixel intensity per unit area \[*n* = 100 cells\]: WT, 3.2 ± 0.8; *dnf1∆ dnf2∆ dnf3Δ*, 1.4 ± 0.4). Immunoblotting demonstrated that the difference in PM decoration by GFP-C2^Lact^ was not due to any difference in expression of this probe ([Figure 6B](#F6){ref-type="fig"}). Thus, in the triple mutant, inward movement of PtdSer appears to be highly defective.

There is no corresponding genetically encoded probe to assess inner-leaflet PtdEth. Hence we used an indirect measure of the efficiency of PtdEth translocation from the outer to the inner leaflet. The killing action of the antibiotic duramycin involves its specific binding to PtdEth on the exocellular surface of the PM ([@B134]). Hence the more PtdEth in the outer leaflet, the more sensitive a yeast cell is to duramycin ([@B87]). Using an agar diffusion bioassay ([Figure 6C](#F6){ref-type="fig"}), we indeed found that, at a concentration of duramycin that has no effect on wild-type cells, the *dnf1∆ dnf2∆ dnf3∆* triple mutant displayed a large zone of cell death, and analysis of double mutants indicated that Dnf1 and Dnf2 are the flippases primarily responsible for the inward movement of PtdEth.

Presumably, in the absence of sufficient inner-leaflet PtdSer, Cdc42 is less efficiently recruited to the PM; however, whatever PM-associated Cdc42-GTP is there will have a more protracted lifetime because, in the absence of sufficient inner-leaflet PtdEth, GAP and GDI activity will be less efficient. As one means to assess which of these two effects is the more dominant, we examined the subcellular localization of the Cdc42 GEF (Cdc24) because there is ample evidence that Cdc42-GTP participates in a self-reinforcing positive feedback loop to stably recruit Cdc24 to the site of apical bud growth ([@B16]; [@B44]; [@B18]). Indeed, we found (Supplemental Figure S6) that, compared with the control, in the *dnf1∆ dnf2∆ dnf3∆* cultures a much larger fraction of the cells with medium or large buds had readily detectable GFP-Cdc24 at the site of apical bud growth, which suggests that GAP- and/or GDI-mediated down-regulation of Cdc42-GTP is impaired. At this time, however, how this mild morphogenetic anomaly may be connected to the slightly elevated Cln2 and slightly reduced Clb2 level observed in *dnf1∆ dnf2∆ dnf3∆* cells is unclear, aside from the fact that perturbations of Cdc42 function might be expected to delay cell cycle progression.

Recruitment of Ste5 to the plasma membrane is impaired in *dnf1∆ dnf2∆ dnf3Δ* cells
-----------------------------------------------------------------------------------

If the primary defect in mounting an efficacious pheromone response in *dnf1∆ dnf2∆ dnf3Δ* cells is due to the low level of Ste5, then ectopic overexpression from a strong promoter should ameliorate the problem. Toward this end, we overexpressed *STE5* from the *GAL1* promoter on a multiple-copy plasmid in *dnf1∆ dnf2∆ dnf3Δ* cells and indeed found that the fraction of the population competent to form robust shmoos in response to α-factor treatment was increased by an order of magnitude, from 4% ([Figure 2A](#F2){ref-type="fig"}) to \>40% ([Figure 7A](#F7){ref-type="fig"}, left). However, we noted that the frequency of shmoo formation was still not at the level displayed by wild-type cells in either the absence ([Figure 2A](#F2){ref-type="fig"}) or presence of overexpressed *STE5* ([Figure 7A](#F7){ref-type="fig"}, left). Hence we overexpressed in the same manner a mutant allele of Ste5, Ste5(P44L) ([@B98]), which has been shown to enhance association of Ste5 with the PM ([@B128]). Although this construct was slightly toxic to the cells, the efficiency of shmoo formation by the *dnf1∆ dnf2∆ dnf3Δ* cells was now equivalent to that exhibited by the wild-type cells ([Figure 7A](#F7){ref-type="fig"}, middle), suggesting that, in addition to the lower steady-state level of Ste5 in *dnf1∆ dnf2∆ dnf3Δ* mutants, the lack of these flippase creates a PM milieu that is less conducive to Ste5 recruitment. However, when overexpressed, the GFP-tagged versions of both wild-type Ste5 and the constitutively active Ste5(P44L) allele were recruited to the shmoo tip in the pheromone-treated cells (Supplemental Figure S7).

![Ste5 tethering at the PM is disturbed in *dnf1∆ dnf2∆ dnf3Δ*. (A) Either WT (BY4741) or *dnf1∆ dnf2∆ dnf3∆* cells (PFY3272C) overexpressing from the *GAL1* promoter either Ste5 (pCJ6) or Ste5(P44L) (pCS7), as indicated, from *URA3*-marked, YEp352-derived plasmids, and *ste5∆* derivatives of the same strains overexpressing Ste5(R407S K411S) from the same vector, which were grown to mid--exponential phase in SCGlc-Ura, collected, resuspended in SCGal-Ura, propagated for 3--4 h, incubated with 10 μM α-factor for 1.5 h, and examined in the microscope. Values are the mean ± SD from three independent trials. (B) Left, a *URA3*-marked *CEN* plasmid (pPP1872) expressing the PtdIns(4,5)P~2~-specific probe GST-GFP-PH^PLCδ1^ was introduced into the control and the *dnf1∆ dnf2∆ dnf3∆* mutant, which were then treated as in A and viewed by fluorescence microscopy. Scale bar, 5 μm. Right, samples of the same cells were lysed, and equivalent amounts of protein from the whole-cell extracts were resolved by SDS--PAGE and analyzed by immunoblot with appropriate antibodies. (C) As in B, except that the *URA3*-marked *CEN* plasmid expressed the PtdIns4P-specific probe 2XPH^Osh2^-GFP.](134fig7){#F7}

To initiate and maintain a signal in response to pheromone, recruitment of Ste5 to the PM requires binding of its PH domain to PtdIns(4,5)P~2~ ([@B40], [@B39]). Indeed, in the absence of endogenous Ste5, overexpression of a Ste5 mutant, Ste5(R407S K411S), unable to interact stably with the PM due to lack of a functional PH domain ([@B40], [@B39]), was unable to support robust shmoo formation in either wild-type or *dnf1∆ dnf2∆ dnf3Δ* cells ([Figure 7A](#F7){ref-type="fig"}, right). As one means to assess PM PtdIns(4,5)P~2~ content and distribution, we first examined localization of a fluorescence probe (GST-GFP-PH^PLCδ1^) that contains the PH domain derived from mammalian PLCδ1, which is highly specific for recognition of PtdIns(4,5)P~2~ ([@B106]; [@B110]). We observed that, compared with control cells, the *dnf1∆ dnf2∆ dnf3∆* mutant exhibited both a reduction in overall intensity and much less decoration of the PM in mother cells than in buds ([Figure 7B](#F7){ref-type="fig"}, left). Immunoblotting of the same cells showed that this difference was not attributable to any difference in the level of probe expression ([Figure 7B](#F7){ref-type="fig"}, right). By contrast, using a PtdIns4P-specific probe that contains tandem copies of the PH domain of yeast Osh2 ([@B92]), we did not observe any difference in either intensity or pattern between control cells and *dnf1∆ dnf2∆ dnf3∆* mutant ([Figure 7C](#F7){ref-type="fig"}).

Mss4 is mislocalized in *dnf1∆ dnf2∆ dnf3Δ* cells
-------------------------------------------------

PtdIns4P is converted to PtdIns(4,5)P~2~ by the sole PtdIns4P 5-kinase in yeast Mss4 ([@B5]; [@B107]), and an *mss4^ts^* mutant fails to recruit Ste5 to the PM and is unable to respond to pheromone at the nonpermissive temperature ([@B39]). When Ste5 cannot be stably tethered at the PM, it is subject to rampant degradation in the nucleus ([@B38]). Hence inefficient generation of PM PtdIns(4,5)P~2~ could explain both the lower level of Ste5 and the signaling defect observed in *dnf1∆ dnf2∆ dnf3∆* cells. For these reasons, we examined the subcellular localization of Mss4.

When expressed at a near-endogenous level (from its native promoter on a *CEN* plasmid) in wild-type cells, Mss4-GFP decorated the inner perimeter of the PM as a series of bright puncta, as observed before ([@B5]), whereas in *dnf1∆ dnf2∆ dnf3∆* cells, the intensity of the PM decoration was reduced by \>70% (average PM pixel intensity per unit area \[*n* = 100 cells\]: WT, 2.6 ± 0.5; *dnf1∆ dnf2∆ dnf3Δ*, 0.7 ± 0.2; [Figure 8A](#F8){ref-type="fig"}, left, top). Immunoblotting demonstrated that this difference in PM decoration by Mss4-GFP was not due to any difference in expression ([Figure 8A](#F8){ref-type="fig"}, right). When Mss4-GFP was overexpressed, the PM decoration was much brighter, and some nuclear localization was observed in wild-type cells, as also observed previously ([@B5]); however, in the *dnf1∆ dnf2∆ dnf3∆* mutant, the PM decoration was increased only slightly, and a unique, internal, apparently vesicular compartment was prominent ([Figure 8A](#F8){ref-type="fig"}, left, bottom).

![Mislocalization of Mss4 in *dnf1∆ dnf2∆ dnf3Δ* cells. (A) Left, *URA3*-marked *CEN* plasmids expressing Mss4-GFP from the *MSS4* promoter (pCS321; top) or from the *GAL1* promoter (pRB2; bottom) were introduced into WT (BY4741) and *dnf1∆ dnf2∆ dnf3Δ* (PFY3272C) cells. The resulting transformants were grown to mid--exponential phase in SCGlc-Ura (top) or shifted to SCGal-Ura for 3 h (bottom) and then examined by fluorescence microscopy. Scale bar, 5 μm. Right, samples of the same cells were lysed, and equivalent amounts of protein from the whole-cell extracts were resolved by SDS--PAGE and analyzed by immunoblot with appropriate antibodies. (B) WT and *dnf1∆ dnf2∆ dnf3∆* cells were transformed with an empty *LEU2*-marked multicopy vector (YEp351GAL) or the same vector expressing from the *GAL1* promoter *MSS4* (pES4), a catalytically inactive (KD) allele Mss4(D636A) (pES20), a *URA3*-marked multicopy vector expressing *STE5* from the *GAL1* promoter (pCJ6), or both the *MSS4*- and *STE5*-expressing plasmids together. The resulting transformants were grown to mid--exponential phase in SCGlc-Leu, SCGlc-Ura, or SCGlc-Leu-Ura, as appropriate, collected, resuspended in SCGal-Leu, SCGal-Ura, or SCGal-Leu-Ura for 3 h, incubated with 10 μM α-factor for 1.5 h, and examined by microscopy. Values are mean ± SD from three independent experiments. (C) WT (BY4741) and otherwise isogenic *cho1∆* (JTY6525) carrying a plasmid (pRB2) expressing *MSS4* under control of the *GAL1* promoter were grown to mid--exponential phase in SCGal-Ura and examined by fluorescence microscopy. Scale bar, 5 μm.](134fig8){#F8}

If mislocalization of Mss4 and a resulting diminution of PM PtdIns(4,5)P~2~ in *dnf1∆ dnf2∆ dnf3Δ* cells contributes to Ste5 instability by preventing its PM recruitment and thereby blocking an efficacious pheromone response, then ectopic overexpression from a strong promoter should ameliorate the problem. Toward this end, we overexpressed *MSS4* from the *GAL1* promoter on a multiple-copy plasmid in *dnf1∆ dnf2∆ dnf3Δ* cells in the absence and presence of overexpressed *STE5*. Overexpression of *MSS4* alone, but not a catalytically inactive mutant, Mss4(D636A) ([@B85]; [@B59]), significantly increased (fourfold) the fraction of the population competent to form robust shmoos in response to α-factor treatment and further enhanced the effect of overproducing Ste5 in a modest but statistically significant manner, such that the frequency of cells in the population competent to respond to pheromone was now close to 90% of that of the wild-type cells carrying empty vector ([Figure 8B](#F8){ref-type="fig"}).

As we demonstrated here, the *dnf1∆ dnf2∆ dnf3Δ* cells have lower levels of inner-leaflet PtdSer and PtdEth ([Figure 6](#F6){ref-type="fig"}). As an independent means to determine whether lower levels of either of these glycerophospholipids might be responsible for lack of efficient Mss4 localization at the PM, we examined the distribution of Mss4-GFP in a *cho1∆* mutant that lacks phosphatidylserine synthase and hence is unable to make PtdSer but can still make PtdEth via a salvage pathway ([@B49]). Indeed, consistent with the lower level of inner-leaflet PtdSer in *dnf1∆ dnf2∆ dnf3∆* cells being responsible for the poor PM recruitment and mislocalization of Mss4, we found that, in *cho1∆* cells, Mss4 localized more weakly to the PM than in wild-type cells (average PM pixel intensity per unit area \[*n* = 100 cells\]: WT, 1.4 ± 0.2; *cho1∆*, 0.74 ± 0.11) and very prominently to the same internal, apparently vesicular compartment seen in the *dnf1∆ dnf2∆ dnf3∆* mutant ([Figure 8C](#F8){ref-type="fig"}).

Through its generation of PtdIns(4,5)P~2~, Mss4 has been implicated in the establishment of cell polarity ([@B78]; [@B130]). Given the aberrations in Mss4 localization we observed in *dnf1∆ dnf2∆ dnf3Δ* cells, it was possible that there might be corresponding perturbation of the actin cytoskeleton. However, when fixed and stained with Alexa Fluor 488--labeled phalloidin, actin patch distribution, actin cable formation, and overall cytoskeletal organization in *dnf1∆ dnf2∆ dnf3Δ* cells appeared quite comparable to those in control cells (Supplemental Figure S8). Hence the failure of shmoo formation in *dnf1∆ dnf2∆ dnf3Δ* cells is not likely an indirect consequence of defects in the actin cytoskeleton.

Distribution of phosphoinositides is grossly aberrant in *dnf1∆ dnf3∆ drs2∆* cells
----------------------------------------------------------------------------------

We found that another flippase triple mutant, *dnf1∆ dnf3∆ drs2∆*, also was defective in pheromone response ([Figure 2, A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}), although not quite as severe as *dnf1∆ dnf2∆ dnf3∆* cells.

However, *dnf1∆ dnf3∆ drs2∆* cells did not exhibit a dramatic reduction in the total level of Ste5 present (Supplemental Figure S9), indicating a different underlying cause for their inability to respond to pheromone. Given the interplay between PM PtdIns(4,5)P~2~ level and Ste5 stability and function that we uncovered in the course of analyzing the signaling defect in the *dnf1∆ dnf2∆ dnf3∆* cells, we used the same probes to examine the distribution of PtdIns(4,5)P~2~, PtdIns4P, and Mss4 in the *dnf1∆ dnf3∆ drs2∆* cells.

The PtdIns4P that is converted to PtdIns(4,5)P~2~ at the PM by the action of Mss4 can be supplied either by direct synthesis at the PM by the essential PtdIns 4-kinase Sst4 or delivered via Golgi compartment--derived secretory vesicles that contain PtdIns4P generated by the Golgi body--associated essential PtdIns 4-kinase Pik1 ([@B107]). We found that, compared with control cells, the distribution of the PtdIns(4,5)P~2~-specific probe was strikingly different in the *dnf1∆ dnf3∆ drs2∆* mutant. Although there was faint decoration of the PM, the most prominent fluorescent feature was several bright internal puncta ([Figure 9](#F9){ref-type="fig"}, top). In the *dnf1∆ dnf3∆ drs2∆* population, \>70% of the cells exhibited such prominent dots, whereas \<8% of wild-type cells had any sort of visible internal feature. Similarly, unlike in wild-type cells, where overexpressed Mss4-GFP is confined to the PM but faintly visible in the nucleus, the Mss4-GFP in *dnf1∆ dnf3∆ drs2∆* cells was reduced at the PM and most prominent in a number of very bright internal puncta ([Figure 9](#F9){ref-type="fig"}, bottom). We suspect that the reduction in PM-associated Mss4 and consequent dramatic reduction in PM PtdIns(4,5)P~2~ could be sufficient, by themselves, to compromise the efficiency of Ste5 recruitment to the PM and hence readily explain the signaling defect observed in *dnf1∆ dnf3∆ drs2∆* cells.

![Phosphoinositide distribution is markedly perturbed in *dnf1∆ dnf3∆ drs2∆* cells. *URA3*-marked plasmids expressing under the *GAL1* promoter either GST-GFP-PH^PLCδ1^ (top), (PH^Osh2^)~2~-GFP (middle), or Mss4-GFP (bottom) were introduced into wild-type cells (BY4741) or an otherwise isogenic *dnf1∆ dnf3∆ drs2∆* (ZHY708) triple mutant, and the resulting transformants were grown to mid--exponential phase in SCGlc-Ura, collected, resuspended in SCGal-Ura medium for 3 h, and then examined by fluorescence microscopy. Scale bar, 5 μm.](134fig9){#F9}

Similarly, localization of the PtdIns4P-specific probe in *dnf1∆ dnf3∆ drs2∆* cells was much less polarized than in the wild-type cells, markedly reduced at the PM, and mainly confined to small vesicles distributed roughly equally between mother and bud ([Figure 9](#F9){ref-type="fig"}, middle). These findings indicate that, in *dnf1∆ dnf3∆ drs2∆* cells, vesicle-mediated outbound lipid and protein trafficking is impaired, preventing efficient provision of phosphoinositides to the PM. Although phosphoinositides were not examined in prior work, our results are consistent with previous studies demonstrating that the lack of Drs2, or additional flippases in combination with Drs2, causes defects in secretory vesicle formation and trafficking from the Golgi structure to the PM, as well as in delivery of late and early endosomes to the Golgi ([@B20]; [@B37]; [@B96]).

DISCUSSION
==========

In yeast and other eukaryotes, PM bilayer composition undergoes continual remodeling due to insertion of secretory vesicles ([@B71]), removal of endocytic vesicles ([@B124]), and action of dedicated transporters that catalyze ATP-dependent transfer of lipids from one leaflet to the other ([@B24]; [@B122]). The class 4 P-type ATPases that constitute the lipid flippase family in yeast ([@B25]; [@B113]; [@B65]) act on different glycerophospholipids in various cellular compartments ([@B73]; [@B96]). It seems remarkable, therefore, that a yeast cell missing three of its five flippases can survive and manifests only modest morphological abnormalities despite rather profound dislocations in PM lipids, as documented here. However, flippase dysfunction has its consequences. As shown here, signaling in the mating pheromone response pathway is abrogated, due largely to effects on stability, recruitment, and/or function of MAPK scaffold protein Ste5.

In *dnf1∆ dnf2∆ dnf3∆* cells, we traced the primary problem to inefficient PM recruitment of Mss4 and consequent reduction in PtdIns(4,5)P~2~. Stable PM recruitment of Ste5 requires its PtdIns(4,5)P~2~-specific PH domain ([@B40], [@B39]), and PM tethering spares Ste5 from degradation in the nucleus ([@B108]; [@B38]). Hence lack of optimal Mss4-generated PtdIns(4,5)P~2~ explains both the lower level of Ste5 and the signaling defect observed in *dnf1∆ dnf2∆ dnf3∆* cells. Indeed, overexpression of both Mss4 and Ste5 largely ameliorated the signaling defect in these cells. Although several proteins are involved in PM localization of Stt4, including Sfk1 ([@B4]), Ypp1, and Efr3 ([@B6]), no such factor has yet been implicated in formation of the PM-associated puncta that contain Mss4, which are distinct from those harboring Stt4 ([@B4]). If there are such proteins for Mss4, then our findings indicate that leaflet lipid composition may be important for their trafficking and delivery to the PM. In Mss4 (779 residues), the catalytic domain is located at its C-terminus (residues 376--769), whereas its N-terminal segment (1--375) contains no recognizable diagnostic folds. Hence perhaps the N-terminal region of Mss4 possesses protein--protein interaction elements and/or lipid-binding motifs or domains important for its PM interaction. There is some evidence that PM sphingolipid content influences Mss4 binding ([@B59]; [@B36]).

In *dnf1∆ dnf3∆ drs2∆* cells, the previously characterized defect these cells exhibit in global trafficking and secretion from the Golgi compartment to the PM ([@B20]; [@B37]; [@B96]) could explain its defective pheromone response, which was somewhat less severe than that of *dnf1∆ dnf2∆ dnf3∆* cells. As shown here, the bulk of the PtdIns(4,5)P~2~ and of its precursor (PtdIns4P) remains on internal membranes and thus is not efficiently delivered to the PM. In this regard, Pik1-generated PtdIns4P in the Golgi compartment binds to the C-terminal tail of Drs2 and stimulates its function ([@B75]), suggesting that Drs2 may only be fully operative and hence able to optimally generate Golgi-derived transport vesicles when Golgi membranes are sufficiently enriched in PtdIns4P. Similarly, Osh4, which specifically binds PtdIns4P, facilitates exocyst complex--mediated secretory vesicle docking at sites of polarized growth at the PM ([@B1]; [@B42]). Therefore the substantial defect we observed in PM PtdIns(4,5)P~2~ in *dnf1∆ dnf3∆ drs2∆* cells may be due, in large measure, to inefficient delivery of its precursor PtdIns4P, further suggesting that the PM-associated PtdIns 4-kinase Stt4 is not sufficient to perform this task in these cells.

In any event, PtdIns(4,5)P~2~ mislocalization has significant consequences for the capacity of the cell to respond to pheromone. In this situation, because both its PH domain ([@B40]; [@B39]) and PM element ([@B128]) display marked preference for interaction with PtdIns(4,5)P~2~, any Ste5 that traffics from the nucleus will be recruited to the cytosolic surface of internal membranes rather than to the PM but nonetheless be spared from degradation. Consistent with this prediction, we found that, in contrast to *dnf1∆ dnf2∆ dnf3∆* cells, the steady-state level of Ste5 in *dnf1∆ dnf3∆ drs2∆* cells was not markedly reduced. However, because neither PtdIns(4,5)P~2~ nor, consequently, Ste5 gets efficiently delivered to the PM, this scaffold protein will not encounter the other components of the pheromone-activated signaling apparatus (in particular, MAPKKKK Ste20) at a level sufficient to activate the Ste5-associated passenger proteins, especially the next enzyme (MAPKKK Ste11) in the MAPK cascade. These considerations likely explain the signaling deficiency of *dnf1∆ dnf3∆ drs2∆* cells. Consistent with these conclusions, we found that overexpression of Ste5(P44L), an allele that enhances the PM targeting ability of the N-terminal amphipathic helix (PM motif) in Ste5, which can interact with other acidic phospholipids, like PtdSer ([@B128]), unlike the PH domain of Ste5 ([@B129]), rescued fully the shmoo formation defect of *dnf1∆ dnf3∆ drs2∆* cells (unpublished data).

In wild-type cells responding to pheromone, Dnf1, Dnf2, and Dnf3, as well as the flippase-activating protein kinase Fpk1, exhibited dramatic relocalization to the shmoo tip. For Dnf1 and Dnf2, appearance at the tip was much more concentrated and sustained than that exhibited by Dnf3. In contrast to the other three flippases, Drs2 was visualized only in Golgi structures, with no difference in localization between vegetative and pheromone-treated cells. However, cells lacking Drs2 show a significant defect in protein transport from the *trans*-Golgi network and a reduction in the amount of Dnf1 at the cell surface ([@B20]; [@B52]). Hence Drs2 activity could indirectly influence Dnf1 function (and, likewise, Dnf2 and Dnf3).

Pheromone-evoked changes result in higher inner-leaflet PtdSer ([@B34]) and lower inner-leaflet PtdEth ([@B55]) at the shmoo tip. Thus, somehow, coordination among the three Fpk1-regulated flippases enhances the rate of inward PtdSer translocation at the expense of inward PtdEth movement. Consistent with this conclusion, the amount of PtdSer in the inner leaflet of the PM was highly reduced in *dnf1∆ dnf2∆ dnf3∆* cells, as judged by the GFP-C2^Lact^ probe. Our result is also in accord with a study showing no change in total PtdSer content in a *dnf1∆ dnf2∆ dnf3∆* mutant compared with wild type, yet enhanced binding of another PtdSer-specific probe, annexin V, to the exocellular surface of the PM in the mutant cells relative to wild type ([@B21]).

Elevated inner-leaflet PtdSer enhances PM localization of Cdc42-GTP ([@B34]), and reduced inner-leaflet PtdEth compromises the action of Cdc42-specific GAPs ([@B94]) and/or the Cdc42-directed GDI ([@B26]) that down-regulate Cdc42-GTP. Thus the membrane environment established in response to pheromone is conducive to maintaining a highly localized, PM-associated pool of Cdc42 in its active (GTP-bound) form, which, in turn, can stimulate the tip-associated formin Bni1 to generate actin cables that direct highly polarized secretion to support mating projection formation ([@B13]; [@B83]).

In naive cells, Dnf1 and Dnf2 are localized throughout the PM perimeter, especially within daughters once cells have budded and at the bud neck and site of cell separation late in the cell cycle, whereas the majority of Dnf3 is in internal vesicles. The observed changes in localization during cell cycle progression and in response to pheromone (when the cells are arrested in G1) suggest that Dnf1, Dnf2, and Dnf3 localization and perhaps function are under control by the cell cycle machinery. In this regard, Dnf2 was identified among likely targets of Cdk1-Clb2 in an unbiased in vitro screen for novel substrates ([@B119]). In addition, the flippase-activating protein kinase Fpk1 is itself under negative regulation by stress-induced protein kinase Ypk1 ([@B87]) and cell cycle--dependent protein kinase Gin4 ([@B135]). Whether Dnf1, Dnf2, and/or Dnf3, or Fpk1, Ypk1, or Gin4, are also under direct control of the pheromone-activated MAPK Fus3 remains important to investigate.

As shown here, PM lipid remodeling mediated by flippases is important for establishing conditions permissive for activation of the mating pheromone response machinery. Moreover, our studies revealed a previously unappreciated interplay between membrane phosphoinositide composition and the leaflet distribution of other classes of glycerophospholipids. It is possible that an adequate content of glycerophospholipids like PtdEth and PtdSer is necessary because their amino groups are positioned to serve as counterions for the negatively charged phosphate groups in the head groups of neighboring phosphoinositides ([@B103]). PtdIns4P and PtdIns(4,5)P~2~ have been implicated in PM recruitment of proteins involved in the cell wall integrity pathway, such as Rho1 and some of its effectors ([@B62]). Hence, in addition to mating pheromone response, other specific PM-associated signaling processes may be similarly defective in flippase-deficient cells.

MATERIALS AND METHODS
=====================

Strains and growth conditions
-----------------------------

Yeast strains used in this study are listed in [Table 1](#T1){ref-type="table"} and were grown routinely at 30˚C. Yeast cells were cultivated in either standard rich (YP) or defined minimal (SC) medium ([@B101]) containing either 2% glucose (Glc), 2% raffinose and 0.2% sucrose (Raf-Suc), or 2% galactose (Gal) as the carbon source and, where necessary, supplemented with appropriate nutrients to maintain selection for plasmids. For induction of *GAL1* promoter-driven expression, cells were pregrown to mid--exponential phase in SCRaf-Suc medium, collected, and resuspended in Gal-containing medium (2% final concentration), and incubation was continued for 3 h. Standard yeast genetic techniques were performed according to [@B101]. Strains YELO17 and YELO18 expressing Ste2(7K-to-R)-mCherry from the *STE2* promoter at the *STE2* locus were constructed by amplifying the STE2(7K-to-R)-mCherry-*CaURA3* cassette from genomic DNA of strain YDB119 ([@B7]) using primers Ste2-*Nde*I 5′-GGGTAAGTACATGATGAAACACA-TATGAAGAAA-3′, and Ste2-*Eco*RI, TTGTAGAGCATTCATCACCATCTTAAGCGC-3′. The resulting product was introduced by DNA-mediated transformation into BY4741 and *dnf1Δ dnf2Δ dnf3Δ* cells selecting for Ura^+^ clones. Successful integration at the *STE2* locus was verified by colony PCR ([@B123]). Integration of the *FUS1~prom~-lacZ* reporter gene was accomplished by linearizing pSB286 ([@B117]) with *Sph*I, followed by selection for Ura^+^ transformants, which were then confirmed by colony PCR.

###### 

Yeast strains used in this study.

  Strain     Genotype or description                                                                  Reference or source
  ---------- ---------------------------------------------------------------------------------------- ---------------------
  BY4741     *MAT*a *his3Δ1 leu2Δ0 met15Δ0 ura3Δ0*                                                    [@B17]
  ZHY708     BY4741 *drs2Δ*::*LEU2 dnf1Δ*::*KanMX4 dnf3Δ*::*KanMX4*                                   [@B52]
  PFY3272C   BY4741 *dnf1Δ*::*KanMX4 dnf2Δ*::*KanMX4 dnf3Δ*::*KanMX4*                                 [@B52]
  YLG32      BY4741 *FUS1~prom~::FUS1-lacZ::URA*                                                      [@B38]
  YELO4      BY4741 *drs2Δ*::*LEU2 dnf1Δ*::*KanMX4 dnf3Δ*::*KanMX4 FUS1~prom~::FUS1-LacZ::URA*        This study
  YELO3      BY4741 *dnf1Δ*::*KanMX4 dnf2Δ*::*KanMX4 dnf3Δ*::*KanMX4 FUS1~prom~::FUS1-LacZ::URA*      This study
  YELO9      BY4741 *dnf1Δ*::*KanMX4 dnf2Δ*::*KanMX4*                                                 This study
  YELO10     BY4741 *dnf1Δ*::*KanMX4 dnf3Δ*::*KanMX4*                                                 This study
  YELO13     BY4741 *dnf2Δ*::*KanMX4 dnf3Δ*::*KanMX4*                                                 This study
  YELO12     BY4741 *drs2Δ*::*KanMX4 dnf1Δ*::*KanMX4*                                                 This study
  YELO11     BY4741 *drs2Δ*::*KanMX4 dnf3Δ*::*KanMX4*                                                 This study
  YELO5      BY4741 *dnf1Δ*::*KanMX4*                                                                 This study
  YELO6      BY4741 *dnf2Δ*::*KanMX4*                                                                 This study
  YELO7      BY4741 *dnf3Δ*::*KanMX4*                                                                 This study
  YELO8      BY4741 *drs2Δ*::*LEU2*                                                                   This study
  NRY921     BY4741 *DNF1*-GFP::*HISMX6*                                                              [@B86]
  NRY923     BY4741 *DNF2*-GFP::*HISMX6*                                                              [@B86]
  YEB1       BY4741 *DNF3*-GFP::*URA3*                                                                This study
  YEB2       BY4741 *DRS2*-mCherry::*URA3*                                                            This study
  YEB6       BY4741 *NEO1*-GFP::*URA3*                                                                This study
  YFR191     BY4741 *fpk1Δ::KanMX4*                                                                   [@B87]
  YFR222     BY4741 *fpk2Δ::KanMX4*                                                                   [@B87]
  YFR205     BY4741 *fpk1Δ::KanMX4 fpk2Δ::KanMX4*                                                     [@B87]
  JTY6142    BY4741 *ypk1Δ::KanMX4*                                                                   Research Genetics
  YELO23     BY4741 *ste5Δ::HIS3*                                                                     This study
  YELO 24    BY4741 *ste5Δ::HIS3 dnf1Δ*::*KanMX4 dnf2Δ*::*KanMX4 dnf3Δ*::*KanMX4*                     This study
  YELO38     BY4741 *cln1::HIS3 cln3::LEU2*                                                           This study
  YELO39     BY4741 *cln1::HIS3 cln3::LEU2 dnf1Δ*::*KanMX4 dnf2Δ*::*KanMX4 dnf3Δ*::*KanMX4*           This study
  YEB3       BY4741 *DRS2*-myc13::*HIS3MX6*                                                           This study
  YEB4       BY4741 *DNF1*-myc13::*HIS3MX6*                                                           This study
  YEB5       BY4741 *DNF3*-myc13::*HIS3MX6*                                                           This study
  YEB7       BY4741 *NEO1*-myc13::*HIS3MX6*                                                           This study
  YDB119     BY4741 *SST2*-GFP::*KanMX6 STE2*(7K-to-R)-mCherry*::CaURA3*                              [@B7]
  YELO17     BY4741 *STE2*(7K-to-R)-mCherry*::CaURA3*                                                 This study
  YELO18     BY4741 *dnf1Δ*::*KanMX4 dnf2Δ*::*KanMX4 dnf3Δ*::*KanMX4* Ste2(7KtoR)-mCherry*::CaURA3*   This study
  JTY6525    BY4741 *cho1Δ*::*KanMX4*                                                                 Open Biosystems

Plasmids and recombinant DNA methods
------------------------------------

Plasmids used in this study are listed in [Table 2](#T2){ref-type="table"}. Plasmids were constructed using standard procedures ([@B95]) in *Escherichia coli* strain DH5α. Fidelity of all constructs was verified by nucleotide sequence analysis. Plasmid pRB2 (p*GAL*-*MSS4-*GFP) was constructed using in vivo gap repair ([@B58]). The *MSS4-*GFP sequence was amplified by PCR from genomic DNA of a yeast strain containing a copy of *MSS4-GFP* integrated at the *MSS4* locus ([@B5]) using synthetic oligonucleotide primers (Mss4-1, 5′-TACCTCTATACTTTAACGTCAAGGAGAAAA­AA­CCCCATGTCAGTCTTGCGATCACCACCTCCT-3′, and Mss4-2, 5′-ATGGGTACCCTACCTACTTGATATGTTACTGGTGGCGCCACCGCCGGCGAGATCTTGATC-3′). The resulting product and *URA3*-marked plasmid pRS316-*GAL1,10*, which had been digested with *Bam*HI and *Spe*I restriction enzymes, were introduced by DNA-mediated transformation ([@B79]) into BY4741, and Ura^+^ transformants were selected on SCGlc-Ura medium. Candidate clones were extracted, plasmid DNA was recovered in *E. coli*, and presence of the desired insert was assessed by agarose gel electrophoresis and confirmed by nucleotide sequence analysis.

###### 

Plasmids used in this study.

  Plasmid         Description                                      Reference or source
  --------------- ------------------------------------------------ ---------------------
  pSB286          *FUS1~prom~::FUS1-LacZ*                          [@B117]
  pFR150          pRC181-*TPI1~prom~*-*FPK1*-GFP::*LEU2*           [@B87]
  YEp352GAL       2 μm DNA ORI, *URA3*, *GAL1~prom~* vector        [@B11]
  pAM76           YEp352-*GAL~prom~*-*YPK1*-*myc*                  [@B90]
  pJT1126         YEp352-*GAL~prom~*-*ypk1(K376A)*-*myc*           [@B90]
  pS5Kmyc         *STE5~prom~*-*STE5*-myc13                        [@B128]
  pCS52           YCpU*GAL*-*STE5*-GFP                             [@B98]
  pCS7            YEp352-*GAL-STE5*(P44L)                          [@B98]
  pCS18           YCplac111-*GAL1~prom~*-*STE5*(P44L)-GFP          [@B98]
  pLG35           YCplac111-*GAL1~prom~*-*ste5*(R407S K411S)-GFP   [@B40]
  pS5Kmyc/NLSm    Ste5*~prom~*-*ste5*(NLSm)-myc                    [@B128]
  pGFP-C2^Lact^   p416-*GPD~prom~*-GFP-C2^Lact^                    Addgene \#22853
  pG-Ste4/18      pRS316-*GAL~prom~*-*STE4/STE18*                  [@B104]
  pCJ6            YEp352-*GAL1-(His)~6-~myc-STE5*                  [@B54]
  pPP1872         pGAL- GST-GFP-PH^PLCδ1^                          [@B39]
  pGFP-OSH2-PH    GFP-2X-PH*^OSH2^*                                [@B92]
  pCS321          pRS416-*MSS4~prom~-MSS4-GFP*                     [@B5]
  pRB2            pRS316-*GAL1-MSS4-GFP*                           This study
  YEp351GAL       2 μm DNA ORI, *LEU2*, *GAL1~prom~* vector        [@B11]
  pES4            YEp351-*GAL1-MSS4-GFP*                           This study
  pES20           YEp351-*GAL1-mss4(D636A)-GFP*                    This study
  pCdc24          p415-*MET25~prom~-GFP-8A-CDC24*                  [@B115]

A catalytically defective ("kinase-dead" \[KD\]) allele, p*GAL1-Mss4(D636A)-GFP* (pES20), was constructed via site-directed mutagenesis using p*GAL1-Mss4-GFP* (pES4) as the template, a pair of phosphorylated synthetic oligonucleotide primers (5′-TTATTCC­TTGTTAATTTGCATT-CATGACAT-3′ and 5′-GCCATTGTATTCAA­TTTA­GCAAGCAATTC-3′), and a single-step plasmid amplification method employing Phusion polymerase ([@B133]), and the resulting construct was confirmed by direct nucleotide sequencing using a reverse synthetic oligonucleotide primer starting 120 base pairs after the GFP start codon (5′-TAAGTTTTCCGTATGTTG-ACTC-3′).

Preparation of cell extracts
----------------------------

Preparation of yeast cell extracts by rapid alkaline lysis followed by trichloroacetic acid (TCA) precipitation was performed as described previously ([@B125]). To extract flippases efficiently from yeast cells, a few modifications were applied. Briefly, cells from samples (3 ml) of mid--exponential--phase cultures were collected and stored at −80°C overnight, and the resulting pellets were resuspended in water (500 μl final volume) and incubated on ice for 10 min with 50 μl of 1.85 M NaOH and 2% β-mercaptoethanol. After this alkaline lysis, protein was precipitated by addition of 50 μl of 50% TCA and, after incubation for 15 min on ice, collected by centrifugation at maximum speed for 5 min at room temperature in a microfuge. The resulting pellets were resuspended in urea-SDS buffer (8 M urea, 5% SDS, 0.1 mM EDTA, 0.1% bromophenol blue, 100 mM dithiothreitol, 200 mM Tris-HCl, pH 6.8), typically 60 μl/1 *A*~600nm~ at time of harvest, heated for 10 min at 37°C, and clarified by centrifugation at maximum speed for 2 min in a microfuge to remove any insoluble debris, and samples of the resulting supernatant solution were stored at −20°C before further analysis.

Antibodies and immunoblotting
-----------------------------

SDS--PAGE and immunoblotting were performed as described previously ([@B125]). Proteins resolved in SDS--polyacrylamide slab gels were transferred to nitrocellulose filter paper, incubated with the appropriate primary antibodies, and then incubated with appropriate infrared dye--conjugated secondary antibodies. The resulting filter-bound immune complexes were then visualized using an Odyssey infrared imaging system (Li-Cor Biosciences, Lincoln, NE) and v2.1 software. Primary antibodies used were polyclonal rabbit anti-Ste5 antiserum ([@B114]; gift of Kirsten Benjamin, Molecular Sciences Institute, Berkeley, CA); mouse monoclonal anti-GFP (Roche Diagnostics, Indianapolis, IN); mouse monoclonal anti-myc (mAb 9E10; [@B32]); rabbit polyclonal anti-Cln2 (CLN2-9099; gift of Karl Kuchler, Medical University of Vienna, Austria); rabbit polyclonal anti-Clb2 (gift of Doug Kellogg, University of California, Santa Cruz, CA); and rabbit polyclonal anti-Pgk1 ([@B10]). Secondary antibodies used were Alexa Fluor 680--conjugated goat anti-rabbit immunoglobulin (IgG; Molecular Probes, Waltham, MA) and IRDye 800--conjugated goat anti-mouse IgG (Rockland Immunochemicals, Limerick, PA). Protein amounts were quantified using ImageJ software (National Institutes of Health, Bethesda, MD) and normalized levels determined as a ratio relative to the loading control (Pgk1).

Quantification of pheromone response pathway
--------------------------------------------

Routinely, to gauge the ability of a given strain to respond to pheromone, the percentage of the cells in a population that were converted to unequivocally recognizable shmoos was assessed after growing the culture to mid--exponential phase, treating it with α-factor (10 μM final concentration) for, typically, 1.5 h, and then examining samples of such cultures by microscopy. As an independent measure of the capacity of cells to respond to pheromone, we used the level of induction of an integrated pheromone-responsive reporter gene, *FUS1-lacZ* (derived from plasmid pSB286), after growing cultures to mid--exponential phase, treating them with α-factor (10 μM final concentration) for, typically, 60 min, and then quantifying the level of β-galactosidase activity present using a colorimetric substrate as described previously ([@B9]).

Epifluorescence and confocal fluorescence microscopy
----------------------------------------------------

To visualize fusion proteins marked with GFP or mCherry, cells were grown to mid--exponential phase and viewed directly under an epifluorescence microscope (Model BH-2; Olympus America, Center Valley, PA) using a 100× objective equipped with appropriate band-pass filters (Chroma Technology, Rockingham, VT). Images were collected using either an Olympus MH-228 charge-coupled device camera (Olympus America) and processed with Magnafire SP imaging software (Optronics, Goleta, CA) or a CoolSnap MYO charge-coupled device camera (Photometrics, Tucson, AZ) and processed with Micro-Manager open source microscopy software ([www.micro-manager.org/](http://www.micro-manager.org/)). For preparation of figures, images were reproduced using Photoshop (Adobe, San Jose, CA). Quantification of the fluorescence in cells was carried out using ImageJ ([@B23]). For each cell, its corrected total PM fluorescence was measured by determining the pixel count within an area delineated by free-form lines drawn around the inner and outer perimeter of the PM and subtracting, as background, the pixel count of an equivalent area in an immediately adjacent cell-free portion of the field. The average PM pixel intensity per unit area is the mean of such measurements performed on at least 100 cells.

Visualization of the subcellular distribution of flippases was also performed using a spinning-disk laser confocal microscopy system (Revolution XD; Andor Technology, South Windsor, CT) comprising an inverted microscope (Nikon TE 2000), a confocal spinning disk unit (model CSU-X1™; Yokogawa Electric Corp., Newman, GA), a piezo-controlled motorized *XYZ* stage, and two charge-coupled device cameras. A PlanSApo 1.4 numerical aperture/100× objective was used with 488-nm or 561-nm laser excitation. The *z*-stacks were deconvolved using Huygens Professional software (version 3.7; Scientific Volume Imaging, Amsterdam, Netherlands). Sum projections were quantified using ImageJ. All samples were imaged in aqueous media, either growth medium, or collected by brief centrifugation and resuspended in phosphate-buffered saline (PBS).

To visualize actin organization, cultures (4.5 ml) were grown to mid--exponential phase and fixed by addition of a formaldehyde solution (670 μl of fresh 37% formaldehyde stock in 0.5 ml of potassium phosphate, pH 6.5) for 1.5 h at room temperature, and the cells were collected by brief centrifugation. After three washes with 0.5 ml of PBS and resuspension in 0.5 ml of PBS, samples (0.2 ml) were incubated in the dark with constant agitation on a roller drum for 30 min with 45 μl of a solution containing Alexa Fluor 488--phalloidin (Life Technologies, Grand Island, NY; 3.3 μM Alexa Fluor 488--phalloidin and 0.1% Triton X-100 in PBS). After three washes with 0.5 ml of PBS, the final cell pellets were resuspended in 15 μl of Fluoroshield mounting buffer (Sigma-Aldrich, St. Louis, MO) and examined by fluorescence microscopy.
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GFP

:   green fluorescent protein

KD

:   kinase-dead mutant

Lact

:   mammalian lactadherin

MAPK

:   mitogen-activated protein kinase

mCherry

:   color variant of monomeric Discoma red fluorescent protein

PH

:   pleckstrin homology domain

PM

:   plasma membrane

PtdEth

:   phosphatidylethanolamine

PtdIns

:   phosphatidylinositol

PtdIns4P

:   phosphatidylinositol-4-phosphate

PtdIns4,5P~2~

:   phosphatidylinositol-4,5-*bis*phosphate

PtdSer

:   phosphatidylserine.
